Your session is about to expire
← Back to Search
Observational for Multiple Myeloma
N/A
Recruiting
Led By Shaji K. Kumar, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up every 3 months, up to 10 years
Awards & highlights
Study Summary
This study evaluates the outcomes of patients undergoing initial therapy for multiple myeloma.
Eligible Conditions
- Multiple Myeloma
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ every 3 months, up to 10 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~every 3 months, up to 10 years
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Overall survival
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,206 Previous Clinical Trials
3,764,714 Total Patients Enrolled
76 Trials studying Multiple Myeloma
7,341 Patients Enrolled for Multiple Myeloma
Shaji K. Kumar, M.D.Principal InvestigatorMayo Clinic in Rochester
8 Previous Clinical Trials
409 Total Patients Enrolled
8 Trials studying Multiple Myeloma
409 Patients Enrolled for Multiple Myeloma
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Share this study with friends
Copy Link
Messenger